No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders
Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan
Evome Medical Technologies Reports Second Quarter 2024 Financial Results
Evome Medical Technologies Retains Irlabs for Investor Relations Services
Evome Medical Technologies Announces Securities Issuances
Evome Medical Technologies Announces Update Call With CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2